1994
DOI: 10.1016/0168-5597(94)90133-3
|View full text |Cite
|
Sign up to set email alerts
|

Somatosensory evoked potentials at rest and during movement in Parkinson's disease: evidence for a specific apomorphine effect on the frontal N30 wave

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

3
39
2

Year Published

1997
1997
2015
2015

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 63 publications
(44 citation statements)
references
References 35 publications
3
39
2
Order By: Relevance
“…The latencies of the main cervical and cortical SEP components were normal, thus confirming indirectly the low incidence of peripheral nerve conduction abnormalities in MSA (2.5). Unlike previous reports (1)(2)(3), the average ratios between parietal N20 and frontal N30 components (P/F index) were not different in patients with parkinsonism (either MSA or PD) compared with normal controls, suggesting that the amplitude of the frontal N30 potential is depressed only in a small percentage (<15% in this series) of patients (5,7). The reason for the discrepancy of findings about N30 behavior in parkinsonian patients is uncertain and is most probably related to selection criteria, such as illness duration or previous medication, as has already been suggested (3,6).…”
Section: Discussioncontrasting
confidence: 85%
See 1 more Smart Citation
“…The latencies of the main cervical and cortical SEP components were normal, thus confirming indirectly the low incidence of peripheral nerve conduction abnormalities in MSA (2.5). Unlike previous reports (1)(2)(3), the average ratios between parietal N20 and frontal N30 components (P/F index) were not different in patients with parkinsonism (either MSA or PD) compared with normal controls, suggesting that the amplitude of the frontal N30 potential is depressed only in a small percentage (<15% in this series) of patients (5,7). The reason for the discrepancy of findings about N30 behavior in parkinsonian patients is uncertain and is most probably related to selection criteria, such as illness duration or previous medication, as has already been suggested (3,6).…”
Section: Discussioncontrasting
confidence: 85%
“…However, later studies have reported conflicting results, some groups supporting the N30 depression (2,3) and others finding no SEP abnormalities ( 4 3 or SEP abnormalities without a clear clinical correlate (6,7).…”
mentioning
confidence: 94%
“…Comparing parkinsonian patients with the healthy population, a relative decrease in N30 component was found, and the potentiation of this component was detected after administration of apomorphine, a dopaminergic agonist. 2,7,8 On the other hand, other investigators have failed to find the putative impairment of the N30 component in Parkinson's disease [9][10][11] or its potentiation by dopaminergic drugs, even in animal models. 12,13 In dystonic patients with either generalized or focal dystonic syndromes, a relative increase in the N30 and P22/N30 amplitudes was found.…”
mentioning
confidence: 96%
“…N30 peak amplitudes are significantly depressed in individuals with Parkinson's disease [47][48][49][50][51][52][53] but are increased with apomorphine (dopamine-agonist) injection [52][53][54] and deep brain stimulation of internal globus pallidus or subthalamic nuclei [54]. As noted above, increased rCBF has been documented in bilateral globus pallidus and putamen with increased movement sequence complexity [16].…”
Section: Enhancements Of Frontal Sepsmentioning
confidence: 92%